tpinto_stats Profile Banner
ArmandoTeixeiraPinto Profile
ArmandoTeixeiraPinto

@tpinto_stats

Followers
254
Following
522
Media
72
Statuses
683

Professor of Biostatistics, University of Sydney, Australia

Joined May 2014
Don't wanna be here? Send us removal request.
@tpinto_stats
ArmandoTeixeiraPinto
6 months
Reporting the involvement of patients and caregivers in identifying and designing healthcare interventions: the IDEAS framework - Journal of Clinical Epidemiology
jclinepi.com
Patient and caregiver involvement can optimize the relevance and uptake of research. However, there is little guidance on approaches for reporting the involvement of patients and caregivers in the...
0
0
4
@kimmonismus
Chubby♨️
8 months
Nvidia showcases Blue, a cute little robot powered by the Newton physics engine. This was the „wow“-moment for me. Robots are coming. This time for real. And I am all in for it!
545
2K
17K
@tpinto_stats
ArmandoTeixeiraPinto
9 months
Patient-reported outcome measures for life participation in patients with chronic kidney disease: a systematic review
Tweet card summary image
academic.oup.com
ABSTRACTBackground. The symptoms, comorbidities and treatment burden associated with chronic kidney disease (CKD) can be debilitating and limit life partic
0
0
2
@tpinto_stats
ArmandoTeixeiraPinto
10 months
•In clinically referred patients, DBT and DM had similar diagnostic accuracy. •DBT and DM had similar cancer diagnostic yield. •DBT had a lower biopsy rate than DM. •DBT may be more accurate than DM in dense breasts. https://t.co/KQbNmeD7w6
0
0
0
@tpinto_stats
ArmandoTeixeiraPinto
1 year
0
0
1
@tpinto_stats
ArmandoTeixeiraPinto
1 year
One-day workshop on statistical methods for longitudinal data (intro level) at the University of Sydney (Westmead Hospital), with an option to join online. This workshop will be co-taught by Professor Jaroslaw Harezlak, Head of the Dep of Biostatistics at Indiana University.
0
4
2
@tpinto_stats
ArmandoTeixeiraPinto
1 year
Normothermic Ex Vivo Perfusion Before Transplantation of the Kidney (NEXT-Kidney): A Single-center, Nonrandomized F…
Tweet card summary image
pubmed.ncbi.nlm.nih.gov
NMP is safe, feasible and efficacious in the Australian setting, with this relatively small cohort demonstrating good early outcomes compared to CS alone in our study of DCD kidneys.
0
0
2
@Kidney_Trials
AKTN
1 year
We are delighted to report the recruitment has started for the M-FIT clinical trial. Find out more here: https://t.co/9QI34Mkcr7. A phenomenal amount of team work to get to this stage.
1
1
4
@Kidney_Trials
AKTN
1 year
Ready, set.....and GO! The first M-FIT trial site @pahospital is now open to recruitment and screening potential participants. The exercise equipment and files are delivered. Watch this space....!
1
1
6
@tpinto_stats
ArmandoTeixeiraPinto
1 year
Preferences in treating polyomavirus infection in kidney transplant recipients: A discrete choice experiment with patients, caregivers, and clinicians in Transplant Infectious Disease https://t.co/X9rFHimMzf
onlinelibrary.wiley.com
In this discrete choice experiment, patients, caregivers, and clinicians were willing to accept higher risks of acute rejection and side effects in exchange for a lower risk of graft loss. Viral...
0
1
3
@tpinto_stats
ArmandoTeixeiraPinto
1 year
Our study https://t.co/xUjVoU3Qyy in the news
0
0
0
@tpinto_stats
ArmandoTeixeiraPinto
1 year
Elon Musk LOSES His COOL During Interview About Remote Work Being MORALL... https://t.co/XyvCHPdKvm via @YouTube
0
0
0
@tpinto_stats
ArmandoTeixeiraPinto
1 year
Causal Relationship Between Kidney Function and Cancer Risk: A Mendelian Randomization Study - American Journal of Kidney Diseases https://t.co/9T7eYCXoK8 @CKRRenal @BEAT_CKD
0
3
7
@elonmusk
Elon Musk
1 year
There are no coincidences
9K
28K
259K